Veracyte, Inc.
VCYT
$30.43
-$0.53-1.71%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.39% | 1.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.39% | 1.25% | |||
| Cost of Revenue | 9.24% | 0.97% | |||
| Gross Profit | -0.44% | 1.37% | |||
| SG&A Expenses | 5.08% | -12.34% | |||
| Depreciation & Amortization | -4.95% | 0.18% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.87% | -4.92% | |||
| Operating Income | -35.63% | 125.71% | |||
| Income Before Tax | -79.56% | 128.88% | |||
| Income Tax Expenses | -198.64% | 4.06% | |||
| Earnings from Continuing Operations | -66.26% | 164.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.26% | 164.30% | |||
| EBIT | -35.63% | 125.71% | |||
| EBITDA | -21.97% | 62.24% | |||
| EPS Basic | -66.51% | 162.75% | |||
| Normalized Basic EPS | -58.47% | 107.51% | |||
| EPS Diluted | -67.74% | 171.43% | |||
| Normalized Diluted EPS | -58.95% | 105.30% | |||
| Average Basic Shares Outstanding | 0.77% | 0.62% | |||
| Average Diluted Shares Outstanding | 1.84% | 1.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
